BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33672564)

  • 1. Antibody Response to Canine Parvovirus Vaccination in Dogs with Hypothyroidism Treated with Levothyroxine.
    Bergmann M; Freisl M; Hartmann K; Speck S; Truyen U; Zablotski Y; Mayr M; Wehner A
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33672564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane.
    Bergmann M; Freisl M; Hartmann K; Speck S; Truyen U; Zablotski Y; Mayr M; Wehner A
    Vaccines (Basel); 2020 Sep; 8(3):. PubMed ID: 32961758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal shedding of canine parvovirus after modified-live vaccination in healthy adult dogs.
    Freisl M; Speck S; Truyen U; Reese S; Proksch AL; Hartmann K
    Vet J; 2017 Jan; 219():15-21. PubMed ID: 28093104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of positive antibody test results for canine parvovirus (CPV) and canine distemper virus (CDV) and response to modified live vaccination against CPV and CDV in dogs entering animal shelters.
    Litster A; Nichols J; Volpe A
    Vet Microbiol; 2012 May; 157(1-2):86-90. PubMed ID: 22261239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Immunity and Seropositivity of IgG Antibodies to Canine Parvoviruses in Vaccinated and Unvaccinated Dogs in Abeokuta, Nigeria.
    Babalola ET; Ijaopo OK; Okonko IO
    J Immunoassay Immunochem; 2016; 37(1):16-28. PubMed ID: 25891124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs.
    Riedl M; Truyen U; Reese S; Hartmann K
    Vet Rec; 2015 Dec; 177(23):597. PubMed ID: 26514756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Challenges in Canine Parvovirus 2c in Vaccine Failure Cases.
    Yip HYE; Peaston A; Woolford L; Khuu SJ; Wallace G; Kumar RS; Patel K; Ahani Azari A; Akbarzadeh M; Sharifian M; Amanollahi R; Jafari Jozani R; Khabiri A; Hemmatzadeh F
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32899378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c.
    Wilson S; Illambas J; Siedek E; Stirling C; Thomas A; Plevová E; Sture G; Salt J
    Vaccine; 2014 Sep; 32(42):5420-4. PubMed ID: 25148778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
    Olson P; Klingeborn B; Hedhammar A
    Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of serum antibody titers against canine distemper virus and canine parvovirus in dogs hospitalized in an intensive care unit.
    Mahon JL; Rozanski EA; Paul AL
    J Am Vet Med Assoc; 2017 Jun; 250(12):1413-1418. PubMed ID: 28569640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of canine parvovirosis - Part 3: Vaccine-associated adverse events].
    Bergmann M; Freisl M; Hartmann K
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2021 Aug; 49(4):294-299. PubMed ID: 34425608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of serologic response to five viral antigens in dogs.
    Mouzin DE; Lorenzen MJ; Haworth JD; King VL
    J Am Vet Med Assoc; 2004 Jan; 224(1):55-60. PubMed ID: 14710876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs.
    Bergmann M; Freisl M; Zablotski Y; Speck S; Truyen U; Hartmann K
    Viruses; 2020 Oct; 12(10):. PubMed ID: 33096809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with canine parvovirus type 2 (CPV-2) protects against challenge with virulent CPV-2b and CPV-2c.
    Siedek EM; Schmidt H; Sture GH; Raue R
    Berl Munch Tierarztl Wochenschr; 2011; 124(1-2):58-64. PubMed ID: 21306055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs.
    Twark L; Dodds WJ
    J Am Vet Med Assoc; 2000 Oct; 217(7):1021-4. PubMed ID: 11019708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Cavalli A; Desario C; Marinaro M; Losurdo M; Camero M; Decaro N; Catella C; Lanave G; Buonavoglia C
    Vaccine; 2020 Jan; 38(2):115-118. PubMed ID: 31628031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination.
    McCaw DL; Thompson M; Tate D; Bonderer A; Chen YJ
    J Am Vet Med Assoc; 1998 Jul; 213(1):72-5. PubMed ID: 9656027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and serological response of wild dogs (Lycaon pictus) to vaccination against canine distemper, canine parvovirus infection and rabies.
    van Heerden J; Bingham J; van Vuuren M; Burroughs RE; Stylianides E
    J S Afr Vet Assoc; 2002 Mar; 73(1):8-12. PubMed ID: 12088076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.
    Coyne MJ
    Vet Ther; 2000; 1(1):35-42. PubMed ID: 19757563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies.
    Hoare CM; DeBouck P; Wiseman A
    Vaccine; 1997 Feb; 15(3):273-5. PubMed ID: 9139485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.